JPRN-UMIN000014382已完成未知
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in Kanagawa - ASSET-K
Diabetes Committee, Kanagawa Physicians Association0 个研究点目标入组 860 人开始时间: 2014年6月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 860
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a history of hypersensitivity to Sitagliptin 2) Patients who have history of diabetic ketoacidosis, or diabetic coma in the past 6 months 3) Patients with serious infectious disease, before operation, serious trauma 4) Patients with severe renal failure
研究者
相似试验
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
已完成
不适用
The efficacy and the safety of the DPP4 inhibitor in patients with type 2 diabetes complicated with renal dysfunctiodiabetes mellitusJPRN-UMIN000030172Osaka Saiseikai Noe Hospital400
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
已完成
不适用
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30
已完成
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100